Data from EMC - Curated by EPG Health - Last updated 23 August 2016
Indication(s)
- Premarin 0.3 mg Coated Tablets:
Hormone replacement therapy for estrogen deficiency symptoms in postmenopausal women.
- Premarin 0.625 mg Coated Tablets / Premarin 1.25 mg Coated Tablets:
− Hormone replacement therapy for estrogen deficiency symptoms in postmenopausal women.
− Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Cardiovascular Metabolism Knowledge Centre
The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.
Migraine Knowledge Centre
The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.
Chronic Obstructive Pulmonary Disease (COPD)
View highlights from recent congresses presented in new expert videos with leading physicians.
+ 7 more
Acute and Advanced Heart Failure
What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...
+ 3 more
CDK 4/6 inhibitors in metastatic breast cancer
The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.
Cushing's Syndrome
Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?
+ 2 more
Allergic Rhinitis
Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.
+ 4 more
Atopic Dermatitis
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
Related Content
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
This study will compare the effect of denosumab produced by two different manufacturing processes on bone mineral density at the...
Added 5 years ago
Vitamin D And Lifestyle Intervention for Gestational Diabetes Mellitus (GDM) Prevention - A European multicentre, randomised trial: Vitamin D limb.
1/ To identify the best available measures to prevent GDM in an ongoing pregnancy 2/ Comparison of the impact of increased...
Added 6 years ago
Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women (ACTIVE)
The purpose of this study is to determine whether BA058 (abaloparatide), a parathyroid hormone-related peptide, is effective in preventing fractures...
Added 8 years ago
Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus
Metformin vs Control to prevent gestational diabetes mellitus (GDM) in women with a high risk for GDM, an open label...
Added 5 years ago
Shockwave Therapy of Chronic Diabetic Foot Ulcers
Introduction: Foot ulcers are a feared complication among diabetic patients. The ulcers can cause pain, discomfort and reduced quality of...
Added 5 years ago
Efficacy of zoledronic acid in treatment of osteoporosis in men and women-a meta-analysis.
Background: Osteoporosis is a significant cause of morbidity and mortality in the elderly and an important public health issue. Bisphosphonates...
Added 3 years ago
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.
Background: Romosozumab is a monoclonal antibody that binds to and inhibits sclerostin, increases bone formation, and decreases bone resorption.
Added 1 year ago
Effects of strontium ranelate on markers of cardiovascular risk in postmenopausal osteoporotic women.
Recent pooled analyses have shown that strontium ranelate increases the incidence of venous thromboembolism and non-fatal myocardial infarction, but no...
Added 3 years ago
Management of osteoporosis and the prevention of fragility fractures
This guideline provides recommendations based on current evidence for best practice in the management of osteoporosis and prevention of fractures.
Added 3 years ago
Menopause: diagnosis and management
This guideline covers the diagnosis and management of menopause, including in women who have premature ovarian insufficiency. The guideline aims to improve the consistency of support and information provided to women in menopause.
Added 3 years ago
Bone health in cancer patients: ESMO Clinical Practice Guidelines
This new ESMO guideline covers areas that make bone health in cancer patients of increasing clinical importance. Besides describing incidence, epidemiology and clinical consequences of bone metastases...
Added 4 years ago
More information
Category | Value |
---|---|
Orphan designation | No |
Type | POM |
Marketing authorisation holder | Pfizer Limited |